Risk factors for lenvatinib‐induced hypertension in patients with hepatocellular carcinoma: A retrospective study
2024 · British Journal of Clinical Pharmacology · 2 citations
https://doi.org/10.1111/bcp.16337
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Maho Nemoto is an academic researcher.
Click to start Chat